Royal Bank of Canada’s Foghorn Therapeutics FHTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Buy |
1,064
+1,030
| +3,029% | +$3.87K | ﹤0.01% | 6297 |
|
|
2025
Q1 | $0 | Sell |
34
-2,555
| -99% | – | ﹤0.01% | 6482 |
|
|
2024
Q4 | $12K | Sell |
2,589
-253
| -9% | -$1.17K | ﹤0.01% | 5795 |
|
|
2024
Q3 | $27K | Sell |
2,842
-6,534
| -70% | -$62.1K | ﹤0.01% | 5529 |
|
|
2024
Q2 | $54K | Buy |
9,376
+928
| +11% | +$5.35K | ﹤0.01% | 5222 |
|
|
2024
Q1 | $57K | Buy |
8,448
+1,947
| +30% | +$13.1K | ﹤0.01% | 5035 |
|
|
2023
Q4 | $42K | Buy |
6,501
+307
| +5% | +$1.98K | ﹤0.01% | 5532 |
|
|
2023
Q3 | $31K | Sell |
6,194
-1,272
| -17% | -$6.37K | ﹤0.01% | 5517 |
|
|
2023
Q2 | $53K | Sell |
7,466
-34
| -0.5% | -$241 | ﹤0.01% | 5306 |
|
|
2023
Q1 | $46K | Buy |
7,500
+1,101
| +17% | +$6.75K | ﹤0.01% | 5282 |
|
|
2022
Q4 | $40K | Buy |
6,399
+2,954
| +86% | +$18.5K | ﹤0.01% | 5540 |
|
|
2022
Q3 | $29K | Buy |
3,445
+132
| +4% | +$1.11K | ﹤0.01% | 5500 |
|
|
2022
Q2 | $46K | Sell |
3,313
-1,089
| -25% | -$15.1K | ﹤0.01% | 5284 |
|
|
2022
Q1 | $67K | Sell |
4,402
-2,716
| -38% | -$41.3K | ﹤0.01% | 5418 |
|
|
2021
Q4 | $162K | Buy |
7,118
+1,571
| +28% | +$35.8K | ﹤0.01% | 5019 |
|
|
2021
Q3 | $78K | Buy |
5,547
+2,959
| +114% | +$41.6K | ﹤0.01% | 5359 |
|
|
2021
Q2 | $27K | Buy |
2,588
+1,309
| +102% | +$13.7K | ﹤0.01% | 5895 |
|
|
2021
Q1 | $17K | Buy |
1,279
+907
| +244% | +$12.1K | ﹤0.01% | 6015 |
|
|
2020
Q4 | $8K | Buy |
+372
| New | +$8K | ﹤0.01% | 5920 |
|